|
RSPRY1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.571960E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.546200E-01 |
| Normal-vs-Stage2 |
2.623800E-01 |
| Normal-vs-Stage3 |
1.922980E-03 |
| Normal-vs-Stage4 |
2.275900E-03 |
| Stage1-vs-Stage2 |
2.927000E-01 |
| Stage1-vs-Stage3 |
2.282900E-03 |
| Stage1-vs-Stage4 |
2.040600E-03 |
| Stage2-vs-Stage3 |
2.949200E-01 |
| Stage2-vs-Stage4 |
2.133000E-01 |
| Stage3-vs-Stage4 |
7.487000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.183900E-02 |
| Normal-vs-AfricanAmerican |
5.182200E-04 |
| Normal-vs-Asian |
4.966000E-01 |
| Caucasian-vs-AfricanAmerican |
1.776450E-02 |
| Caucasian-vs-Asian |
2.768200E-01 |
| AfricanAmerican-vs-Asian |
3.933600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.216700E-03 |
| Normal-vs-Female |
2.047600E-01 |
| Male-vs-Female |
2.979000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.314300E-02 |
| Normal-vs-Age(41-60Yrs) |
3.188200E-01 |
| Normal-vs-Age(61-80Yrs) |
7.696100E-03 |
| Normal-vs-Age(81-100Yrs) |
1.664040E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.853800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.588200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.398600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.296200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.551600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.602200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.830800E-01 |
| Normal-vs-Grade 2 |
2.423400E-01 |
| Normal-vs-Grade 3 |
9.005500E-02 |
| Normal-vs-Grade 4 |
7.61430000000285E-05 |
| Grade 1-vs-Grade 2 |
1.703370E-01 |
| Grade 1-vs-Grade 3 |
1.740810E-01 |
| Grade 1-vs-Grade 4 |
7.877400E-03 |
| Grade 2-vs-Grade 3 |
5.007800E-01 |
| Grade 2-vs-Grade 4 |
4.219400E-04 |
| Grade 3-vs-Grade 4 |
9.604700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.664200E-01 |
| Normal-vs-ccB subtype |
2.198500E-02 |
| ccA subtype-vs-ccB subtype |
6.115100E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.334410E-01 |
| Normal-vs-N1 |
3.131200E-01 |
| N0-vs-N1 |
4.210600E-01 |
|
|
